Device Trial Radar · NCT04272216
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
Last checked: Nov 19, 2026Latest source record: Sep 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99
Actual
Start
Feb 6, 2020
Primary completion
Mar 7, 2022
Study completion Mar 11, 2023
Sponsor
- Lead sponsor
- Terumo Medical CorporationPublic (4543.T)
- Sponsor type
- Industry
- First posted
- Feb 17, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
Conditions
- Uterine Fibroid
- Arteriovenous Malformations
- Hypervascular Tumors
- Benign Prostatic Hyperplasia
Interventions
Treatment with HydroPearl via radial accessDevice
This is an observational study collecting data on patients who are already being treated with HydroPearl on-label per standard of care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedural SuccessTime frame: Duration of procedure (measured from the time the participant is sedated (start of study procedure) until all products are removed from the participant and closure is confirmed (end of the intended study procedure))
- Technical SuccessTime frame: Duration of procedure (from when the injection of HydroPearls is started until access site closure has been completed)
- Freedom From Major Adverse Events and Radial Access ComplicationsTime frame: within 30 days post-procedure
1 more outcomes with a free account
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
University of California - Los Angeles
Los Angeles, California
Rush University Medical Center
Chicago, Illinois
SLU Department of Radiology
St Louis, Missouri
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.